image_pdfimage_print
Prebiotics, probiotics, vitamins and nutrients

BetterNutrition Editors Name Biomunity™ to List of Immune Health Product Picks

NEWS PROVIDED BY
Kibow Biotech, Inc. 

NEWTOWN SQUARE, Penn., March. 18, 2021 /PRNewswire/ — Kibow Biotech is pleased to announce that Biomunity™, its novel, comprehensive immune health supplement product has been named an Editor’s Immune Health Product Pick by BetterNutrition magazine. 

The announcement, on page 31 of the March 2021 issue of BetterNutrition, represents an objective and competitive evaluation of Biomunity.  The list of editors’ picks is featured in an article written by the Vice President of product development for a nutritional products company that features an immune support product—which makes Biomunity’s inclusion on the list even more impressive.

Kibow Biotech is a pioneering and innovative health supplement company using clinically validated and scientifically documented probiotics, prebiotics, and synbiotics towards various healthcare applications.  Biomunity™ has been explicitly designed to help modulate and maintain the immune system against stressors and environmental pathogens. It contains a comprehensive proprietary combination of an immune-nurturing blend of probiotics, prebiotics, vitamins, and nutrients. These ingredients were selected for their demonstrated efficacy, as documented in clinical studies on the human gut microbiome. 

With the probiotics, we selected this unique blend based on our decade of on-market experience.  Our science has demonstrated the ability of this blend to support immunity by restoring intestinal microflora in people with kidney disease who have suppressed immune systems,” explains Kibow Biotech founder and Managing Director Dr. Natarajan Ranganathan. “We have combined these probiotics with a specific, tailored blend of scientifically researched functional prebiotics (fibers), each distinguished for their unique ability to fuel the body’s production of short-chain fatty acids (SCFA).  Third-party research has shown these prebiotics play an important role in the health of the human gut (increasingly referred to as the “microbiome”) and metabolic health.”  

In addition to probiotics and functional prebiotics — and unlike the vast majority of probiotic dietary supplements on the market today — Biomunity™ also includes a unique blend of Vitamin D, Vitamin C (ascorbic acid), CoQ10, Zinc, and Cinnamon. Each of these vitamins and nutrients have documented histories of supporting the human immune system. All Biomunity™ ingredients combine to provide a complete package for immune health available today. 

Kibow’s Biomunity™ represents the next level in dietary support for the immune system. It also delivers the convenience of fewer products to purchase since one box contains five probiotics, five prebiotics, and five vitamins and nutrients. Thanks to the product’s completeness, consumers can save substantially on their self-care by eliminating stand-alone dietary supplements.

Biomunity™ is perfect for anyone working and living under elevated stresses that can weaken their ability to stave off the effects of environmentally acquired pathogens. This exceptional product is available to the public at www.kibowbiomunity.com. The list price of a 30-day supply is $79.00. To applaud, appreciate and honor the frontline workers, Kibow Biotech is pleased to offer a special 25% discounted pricing to all healthcare, law enforcement, and emergency services professionals who purchase on its website – www.kibowbiotech.com

About Kibow Biotech:

Established on October 1, 1997, in Philadelphia, Kibow Biotech specializes in research, development, and commercialization of probiotic dietary supplements adhering to US FDA and FTC regulations. The company’s primary mission is to offer affordable, readily available, and easily administered nutritional supplements to support kidney health and other healthcare applications.  The company’s extensive scientific R&D and clinical data from three different pilot/observational scientific human clinical trials have been published in peer-reviewed scientific/medical journals (http://www.kibowbiotech.com/rd/).

Forward-looking statements:

This press release contains forward-looking statements that reflect management’s current views of future events, including the status of development of the dietary supplements for potential health benefits in the USA and other countries.

For further information, contact:

Jesse Goldberg
Phone: (610) 353-5130
Email: Jesse@kibowbiotech.com 

*These statements have not been evaluated by the US Food and Drug Administration. This product is not Intended to diagnose, treat, cure, or prevent any disease.